Suppr超能文献

人源K-Ras G12D突变体与GDP及环状抑制肽KRpep-2d复合物的晶体结构

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

作者信息

Sogabe Satoshi, Kamada Yusuke, Miwa Masanori, Niida Ayumu, Sameshima Tomoya, Kamaura Masahiro, Yonemori Kazuko, Sasaki Shigekazu, Sakamoto Jun-Ichi, Sakamoto Kotaro

机构信息

Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.

出版信息

ACS Med Chem Lett. 2017 May 10;8(7):732-736. doi: 10.1021/acsmedchemlett.7b00128. eCollection 2017 Jul 13.

Abstract

The Ras proteins play roles in cell differentiation, proliferation, and survival. Aberrant signaling through Ras-mediated pathways in tumor cells occurs as a result of several types of mutational damage, which most frequently affects the amino acids G12, G13, and Q61. Recently, KRpep-2d was identified as a K-Ras(G12D) selective inhibitory peptide against the G12D mutant of K-Ras, which is a key member of the Ras protein family and an attractive cancer therapeutic target. In this study, the crystal structure of the human K-Ras(G12D) mutant was determined in complex with GDP and KRpep-2d at 1.25 Å resolution. This structure revealed that the peptide binds near Switch II and allosterically blocks protein-protein interactions with the guanine nucleotide exchange factor. This discovery of a unique binding pocket provides valuable information that will facilitate the design of direct Ras inhibitors.

摘要

Ras蛋白在细胞分化、增殖和存活中发挥作用。肿瘤细胞中通过Ras介导的信号通路发生异常信号传导是几种类型的突变损伤的结果,其中最常见的是影响氨基酸G12、G13和Q61。最近,KRpep-2d被鉴定为针对K-Ras的G12D突变体的K-Ras(G12D)选择性抑制肽,K-Ras是Ras蛋白家族的关键成员,也是一个有吸引力的癌症治疗靶点。在本研究中,以1.25 Å的分辨率测定了人K-Ras(G12D)突变体与GDP和KRpep-2d复合物的晶体结构。该结构表明,该肽在Switch II附近结合,并通过变构作用阻断与鸟嘌呤核苷酸交换因子的蛋白质-蛋白质相互作用。这一独特结合口袋的发现提供了有价值的信息,将有助于设计直接的Ras抑制剂。

相似文献

1
Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.
ACS Med Chem Lett. 2017 May 10;8(7):732-736. doi: 10.1021/acsmedchemlett.7b00128. eCollection 2017 Jul 13.
2
Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
Bioorg Med Chem Lett. 2017 Jun 15;27(12):2757-2761. doi: 10.1016/j.bmcl.2017.04.063. Epub 2017 Apr 21.
3
K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology.
Biochem Biophys Res Commun. 2017 Mar 11;484(3):605-611. doi: 10.1016/j.bbrc.2017.01.147. Epub 2017 Jan 30.
5
GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf.
ACS Cent Sci. 2020 Oct 28;6(10):1753-1761. doi: 10.1021/acscentsci.0c00514. Epub 2020 Sep 23.
7
Oncogenic G12D mutation alters local conformations and dynamics of K-Ras.
Sci Rep. 2019 Aug 13;9(1):11730. doi: 10.1038/s41598-019-48029-z.
10
In-silico design of peptide inhibitors of K-Ras target in cancer disease.
J Biomol Struct Dyn. 2020 Nov;38(18):5488-5499. doi: 10.1080/07391102.2019.1704880. Epub 2019 Dec 23.

引用本文的文献

1
From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.
Chem Rev. 2025 Jul 23;125(14):6819-6869. doi: 10.1021/acs.chemrev.5c00046. Epub 2025 Jun 24.
3
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function.
J Mol Biol. 2025 Jun 1;437(11):169044. doi: 10.1016/j.jmb.2025.169044. Epub 2025 Feb 25.
4
Advancements in gene therapies targeting mutant KRAS in cancers.
Cancer Metastasis Rev. 2025 Jan 17;44(1):24. doi: 10.1007/s10555-025-10243-9.
5
Motif-guided identification of KRAS-interacting proteins.
BMC Biol. 2024 Nov 19;22(1):264. doi: 10.1186/s12915-024-02067-w.
6
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
7
Exploration of Cryptic Pockets Using Enhanced Sampling Along Normal Modes: A Case Study of KRAS .
J Chem Inf Model. 2024 Nov 11;64(21):8258-8273. doi: 10.1021/acs.jcim.4c01435. Epub 2024 Oct 17.
8
Ligand-induced conformational changes in protein molecules detected by sum-frequency generation.
Biophys J. 2024 Nov 5;123(21):3678-3687. doi: 10.1016/j.bpj.2024.09.017. Epub 2024 Sep 19.
10
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound Engagement.
Anal Chem. 2024 Apr 2;96(13):5223-5231. doi: 10.1021/acs.analchem.3c05626. Epub 2024 Mar 18.

本文引用的文献

1
Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
Bioorg Med Chem Lett. 2017 Jun 15;27(12):2757-2761. doi: 10.1016/j.bmcl.2017.04.063. Epub 2017 Apr 21.
2
K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology.
Biochem Biophys Res Commun. 2017 Mar 11;484(3):605-611. doi: 10.1016/j.bbrc.2017.01.147. Epub 2017 Jan 30.
3
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.
Nat Rev Drug Discov. 2016 Nov;15(11):771-785. doi: 10.1038/nrd.2016.139. Epub 2016 Jul 29.
4
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.
Cancer Discov. 2016 Mar;6(3):316-29. doi: 10.1158/2159-8290.CD-15-1105. Epub 2016 Jan 6.
5
Inhibition of Ras signaling by blocking Ras-effector interactions with cyclic peptides.
Angew Chem Int Ed Engl. 2015 Jun 22;54(26):7602-6. doi: 10.1002/anie.201502763. Epub 2015 May 7.
6
Cancer: The Ras renaissance.
Nature. 2015 Apr 16;520(7547):278-80. doi: 10.1038/520278a.
7
Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
J Med Chem. 2015 Mar 12;58(5):2265-74. doi: 10.1021/jm501660t. Epub 2015 Feb 26.
8
Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Structure. 2015 Mar 3;23(3):505-516. doi: 10.1016/j.str.2014.12.017. Epub 2015 Feb 12.
9
Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1761-6. doi: 10.1073/pnas.1413185112. Epub 2015 Jan 26.
10
Drugging the undruggable RAS: Mission possible?
Nat Rev Drug Discov. 2014 Nov;13(11):828-51. doi: 10.1038/nrd4389. Epub 2014 Oct 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验